LDLR and chronic kidney disease: Hypertriglyceridemia in end-stage renal disease is accompanied by impaired clearance of triglyceride-rich lipoproteins caused by dysregulation of lipoprotein lipase, hepatic lipase, or the very low-density lipoprotein receptor [16].